Thromboelastography in patients with severe sepsis: a prospective cohort study

[1] Angus DC(2013)Severe sepsis and septic shock N Engl J Med 369 840-851

[2] van der Poll T(2004)Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation Crit Care Med 32 2416-2421

[3] Bakhtiari K(2012)Consecutive thrombelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: a prospective study J Crit Care 21 168-174

[4] Meijers JCM(2010)Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality Blood Coagul Fibrinolysis 18 R30-134

[5] de Jonge E(2014)Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review Crit Care 367 124-874

[6] Levi M(2012)Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis N Engl J Med 20 864-2134

[7] Ostrowski SR(1992)American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med 12 24-349

[8] Windeløv NA(2011)Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S-Scandinavian starch for severe sepsis/septic shock trial): study protocol, design and rationale fora double-blinded randomised clinical trial Trials 39 2126-2963

[9] Ibsen M(2013)Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial Intensive Care Med 61 344-710

[10] Johansson PI(2008)The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies J Clin Epidemiol 270 2957-47

[1] Angus DC(2013)Severe sepsis and septic shock N Engl J Med 369 840-851

[2] van der Poll T(2004)Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation Crit Care Med 32 2416-2421

[3] Bakhtiari K(2012)Consecutive thrombelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: a prospective study J Crit Care 21 168-174

[4] Meijers JCM(2010)Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality Blood Coagul Fibrinolysis 18 R30-134

[5] de Jonge E(2014)Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review Crit Care 367 124-874

[6] Levi M(2012)Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis N Engl J Med 20 864-2134

[7] Ostrowski SR(1992)American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med 12 24-349

[8] Windeløv NA(2011)Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S-Scandinavian starch for severe sepsis/septic shock trial): study protocol, design and rationale fora double-blinded randomised clinical trial Trials 39 2126-2963

[9] Ibsen M(2013)Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial Intensive Care Med 61 344-710

[10] Johansson PI(2008)The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies J Clin Epidemiol 270 2957-47